Literature DB >> 17471025

New roads to FA/BRCA pathway: H2AX.

Alex Lyakhovich1, Jordi Surrallés.   

Abstract

We have recently described an involvement of H2AX into the Fanconi anemia (FA) BRCA pathway through recruitment of FA protein FANCD2 to the sites of stalled replication forks. We showed that BRCA1 mediates the recruitment of FANCD2 by gammaH2AX to damaged chromatin and cells deficient or depleted of H2AX exhibit an FA-like phenotype, including an excess of chromatid-type chromosomal aberrations and hypersensitivity to MMC. Here, we discuss a model for the FA pathway and how it could partially explain the common phenotypes of H2AX, BRCA2 and FA deficiencies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17471025     DOI: 10.4161/cc.6.9.4223

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  6 in total

Review 1.  H2AX: functional roles and potential applications.

Authors:  Jennifer S Dickey; Christophe E Redon; Asako J Nakamura; Brandon J Baird; Olga A Sedelnikova; William M Bonner
Journal:  Chromosoma       Date:  2009-08-26       Impact factor: 4.316

Review 2.  The multi-functionality of UHRF1: epigenome maintenance and preservation of genome integrity.

Authors:  Monica Mancini; Elena Magnani; Filippo Macchi; Ian Marc Bonapace
Journal:  Nucleic Acids Res       Date:  2021-06-21       Impact factor: 16.971

3.  Silencing of fanconi anemia complementation group f exhibits potent chemosensitization of mitomycin C activity in breast cancer cells.

Authors:  Jiankun Yu; Lin Zhao; Yanlin Li; Na Li; Miao He; Xuefeng Bai; Zhaojin Yu; Zhihong Zheng; Xiaoyi Mi; Enhua Wang; Minjie Wei
Journal:  J Breast Cancer       Date:  2013-09-30       Impact factor: 3.588

4.  Gene silencing of FANCF potentiates the sensitivity to mitoxantrone through activation of JNK and p38 signal pathways in breast cancer cells.

Authors:  Yanlin Li; Lin Zhao; Haigang Sun; Jiankun Yu; Na Li; Jingwei Liang; Yan Wang; Miao He; Xuefeng Bai; Zhaojin Yu; Zhihong Zheng; Xiaoyi Mi; Enhua Wang; Minjie Wei
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

5.  RNAi-mediated knockdown of FANCF suppresses cell proliferation, migration, invasion, and drug resistance potential of breast cancer cells.

Authors:  L Zhao; N Li; J K Yu; H T Tang; Y L Li; M He; Z J Yu; X F Bai; Z H Zheng; E H Wang; M J Wei
Journal:  Braz J Med Biol Res       Date:  2013-12-12       Impact factor: 2.590

6.  CITED2 silencing sensitizes cancer cells to cisplatin by inhibiting p53 trans-activation and chromatin relaxation on the ERCC1 DNA repair gene.

Authors:  Yu-Chin Liu; Pu-Yuan Chang; Chuck C-K Chao
Journal:  Nucleic Acids Res       Date:  2015-09-17       Impact factor: 16.971

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.